4000-520-616
欢迎来到免疫在线!(蚂蚁淘生物旗下平台)  请登录 |  免费注册 |  询价篮
主营:原厂直采,平行进口,授权代理(蚂蚁淘为您服务)
咨询热线电话
4000-520-616
当前位置: 首页 > 产品中心 > RNA_polymerase > academy biomed/[A03]山羊抗人载脂蛋白AI多克隆抗体/5.0 mg/11A-G2
商品详细academy biomed/[A03]山羊抗人载脂蛋白AI多克隆抗体/5.0 mg/11A-G2
academy biomed/[A03]山羊抗人载脂蛋白AI多克隆抗体/5.0 mg/11A-G2
academy biomed/[A03]山羊抗人载脂蛋白AI多克隆抗体/5.0 mg/11A-G2
商品编号: 11A-G2
品牌: academybiomed
市场价: ¥4360.00
美元价: 2180.00
产地: 美国(厂家直采)
公司:
产品分类: RNA聚合酶
公司分类: RNA_polymerase
联系Q Q: 3392242852
电话号码: 4000-520-616
电子邮箱: info@ebiomall.com
商品介绍
Host Species:Goat
Concentration:1 mg/ml (OD 1.35 / 280 nm)
Antigen:Human Apolipoprotein AI
Purification:Affinity purified
Buffer:75 mM Sodium Phosphate, 75 mM NaCl, 0.5 mM EDTA, 0.02% NaN3, pH 7.2
SpecificitySpecifically binds to human apo AI. Dilution for immunoblot and ELISA range: 1,000 to 80,000.
Use:The antibody can be used for detection of apo AI in plasma and lipoproteins, immunoassays, immunoblots, enzyme conjugation, or biotinylation.
Storage:-20°C for long-term storage, 4°C for short- term storage. Aliquot to avoid repeated freezing and thawing.

 

*These products are for research or manufacturing use only, not for use in human therapeutic or diagnostic applications.

 

Importance

Apo AI comprises approximately 70% of the protein moiety in HDL. It is a single polypeptide chain consisting of 243 amino acid residues without disulfide bound and with glutamic acid as the C-terminal residue and aspartic acid as the N-terminal residue. The molecular weight is reported to be 28 kDa (Brewer et al., 1978).

The roles of Apo AI in HDL function include reverse cholesterol transportation, lipid cholesterol binding, lecithin-cholesterol acyl transferase (LCAT) activation, and receptor binding, which is responsible for cholesterol esterification in plasma. Besides participate in cholesterol metabolism, Apo AI and HDL also suppress neutrophil activation, inhibit bacterial endotoxin, induce trypanosomal lysis, and other physiological activities. (Brouillette et al., 2001)

Apo AI levels may be inversely related to the risk of coronary disease. In previous research, Apo AI may affect diet-induced inflammation by either directly or indirectly altering lipid rafts. (Cheng et al., 2012)

Brewer, H. B., T. Fairwell, A. LaRue, R. Ronan, A. Houser, and T. J. Bronzert. “The amino acid sequence of human Apoa-I, an apolipoprotein isolated from high density lipoproteins.” Biochemical and Biophysical Research Communications 80.3 (1978): 623-30.

Brouillette, Christie G., G.m. Anantharamaiah, Jeffrey A. Engler, and David W. Borhani. "Structural Models of Human Apolipoprotein A-I: A Critical Analysis and Review." Biochimica Et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids (2001): 4-46.

Cheng, Andrew M., Priya Handa, Sanshiro Tateya, Jay Schwartz, Chongren Tang, Poulami Mitra, John F. Oram, Alan Chait, and Francis Kim. "Apolipoprotein A-I Attenuates Palmitate-Mediated NF-κB Activation by Reducing Toll-Like Receptor-4 Recruitment into Lipid Rafts." PLoS ONE 7.3 (2012): e33917.

 

Citations

[A03]2020

Chen, Wei-Yu; Chen, Yun-Fang; Chan, Hua-Cheng; Chung, Ching-Hu; Peng, Hsien-Yu; Ho, Yu-Cheng et al. (2020): Role of apolipoprotein E in electronegative low-density lipoprotein-induced mitochondrial dysfunction in cardiomyocytes. In Metabolism: Clinical and Experimental 107, p. 154227. DOI: 10.1016/j.metabol.2020.154227.

[A03]2020Kelly, Una L.; Grigsby, Daniel; Cady, Martha A.; Landowski, Michael; Skiba, Nikolai P.; Liu, Jian et al. (2020): High density lipoproteins are a potential therapeutic target for age-related macular degeneration. J. Biol. Chem. DOI: 10.1074/jbc.RA119.012305.
[A03]2020Koch, Manja; DeKosky, Steven T.; Goodman, Matthew; Sun, Jiehuan; Furtado, Jeremy D.; Fitzpatrick, Annette L. et al. (2020): High density lipoprotein and its apolipoprotein-defined subspecies and risk of dementia. J. Lipid Res. 61 (3), pp. 445–454. DOI: 10.1194/jlr.P119000473.
[A03]2020Lee, An-Sheng; Wang, Yu-Chen; Chang, Shih-Sheng; Lo, Ping-Hang; Chang, Chia-Ming; Lu, Jonathan et al. (2020): Detection of a High Ratio of Soluble to Membrane-Bound LOX-1 in Aspirated Coronary Thrombi From Patients With ST-Segment-Elevation Myocardial Infarction. Journal of the American Heart Association 9 (2), e014008. DOI: 10.1161/JAHA.119.014008.
[A03]2019Gonen, Ayelet; Choi, Soo-Ho; Miu, Phuong; Agatisa-Boyle, Colin; Acks, Daniel; Taylor, Angela M. et al. (2019): A monoclonal antibody to assess oxidized cholesteryl esters associated with apoAI and apoB-100 lipoproteins in human plasma. J. Lipid Res. 60 (2), pp. 436–445. DOI: 10.1194/jlr.D090852.
[A03]2019Koch, Manja; Fitzpatrick, Annette L.; Rapp, Stephen R.; Nahin, Richard L.; Williamson, Jeff D.; Lopez, Oscar L. et al. (2019): Alcohol Consumption and Risk of Dementia and Cognitive Decline Among Older Adults With or Without Mild Cognitive Impairment. JAMA Network Open 2 (9), e1910319. DOI: 10.1001/jamanetworkopen.2019.10319.
[A03]2019Landowski, Michael; Kelly, Una; Klingeborn, Mikael; Groelle, Marybeth; Ding, Jin-Dong; Grigsby, Daniel; Bowes Rickman, Catherine (2019): Human complement factor H Y402H polymorphism causes an age-related macular degeneration phenotype and lipoprotein dysregulation in mice. Proceedings of the National Academy of Sciences of the United States of America 116 (9), pp. 3703–3711. DOI: 10.1073/pnas.1814014116.
[A03]2019Morton, Allyson M.; Furtado, Jeremy D.; Mendivil, Carlos O.; Sacks, Frank M. (2019): Dietary unsaturated fat increases HDL metabolic pathways involving apoE favorable to reverse cholesterol transport. JCI Insight 4 (7). DOI: 10.1172/jci.insight.124620.
[A03]2019Pagano, Sabrina; Magenta, Alessandra; D"Agostino, Marco; Martino, Francesco; Barillà, Francesco; Satta, Nathalie et al. (2019): Anti-ApoA-1 IgGs in Familial Hypercholesterolemia Display Paradoxical Associations with Lipid Profile and Promote Foam Cell Formation. Journal of Clinical Medicine 8 (12). DOI: 10.3390/jcm8122035.
[A03]2019Schilcher, Irene; Ledinski, Gerhard; Radulović, Snježana; Hallström, Seth; Eichmann, Thomas; Madl, Tobias et al. (2019): Endothelial lipase increases antioxidative capacity of high-density lipoprotein. Biochimica et biophysica acta. Molecular and Cell Biology of Lipids 1864 (10), pp. 1363–1374. DOI: 10.1016/j.bbalip.2019.06.011.
[A03]2018Sato, Megumi; Ohkawa, Ryunosuke; Low, Hann; Nishimori, Madoka; Okubo, Shigeo; Yoshimoto, Akira et al. (2019): Serum amyloid A does not affect high-density lipoprotein cholesterol measurement by a homogeneous assay. In Clinical Biochemistry 63, pp. 97–101. DOI: 10.1016/j.clinbiochem.2018.10.008.
[A03]2018Aroner, Sarah A.; Koch, Manja; Mukamal, Kenneth J.; Furtado, Jeremy D.; Stein, James H.; Tattersall, Matthew C. et al. (2018): High‐Density Lipoprotein Subspecies Defined by Apolipoprotein C‐III and Subclinical Atherosclerosis Measures: MESA (The Multi‐Ethnic Study of Atherosclerosis). In Journal of the American Heart Association 7 (6), p. 40. DOI: 10.1161/JAHA.117.007824.
[A03]2018Furtado, Jeremy D.; Yamamoto, Rain; Melchior, John T.; Andraski, Allison B.; Gamez-Guerrero, Maria; Mulcahy, Patrick et al. (2018): Distinct Proteomic Signatures in 16 HDL (High-Density Lipoprotein) Subspecies. In Arterioscler Thromb Vasc Biol. 38 (12), pp. 2827–2842. DOI: 10.1161/ATVBAHA.118.311607.
[A03]2018Koch, Manja; DeKosky, Steven T.; Fitzpatrick, Annette L.; Furtado, Jeremy D.; Lopez, Oscar L.; Kuller, Lewis H. et al. (2018): Apolipoproteins and Alzheimer"s pathophysiology. In Alzheimer"s & Dementia (Amsterdam, Netherlands) 10, pp. 545–553. DOI: 10.1016/j.dadm.2018.07.001.
[A03]2018Morton, Allyson M.; Koch, Manja; Mendivil, Carlos O.; Furtado, Jeremy D.; Tjønneland, Anne; Overvad, Kim et al. (2018): Apolipoproteins E and CIII interact to regulate HDL metabolism and coronary heart disease risk. In JCI Insight 3 (4). DOI: 10.1172/jci.insight.98045.
[A03]2018Satta, Nathalie; Pagano, Sabrina; Montecucco, Fabrizio; Gencer, Baris; Mach, François; Kaiser, Laurent et al. (2018): Anti-apolipoprotein A-1 autoantibodies are associated with immunodeficiency and systemic inflammation in HIV patients. In The Journal of Infection 76 (2), pp. 186–195. DOI: 10.1016/j.jinf.2017.11.008.
[A03]2017Gillard, Baiba K.; Bassett, G. Randall; Gotto, Antonio M.; Rosales, Corina; Pownall, Henry J. (2017): Scavenger receptor B1 (SR-B1) profoundly excludes high density lipoprotein (HDL) apolipoprotein AII as it nibbles HDL-cholesteryl ester. In J. Biol. Chem. 292 (21), pp. 8864–8873. DOI: 10.1074/jbc.M117.781963.
[A03]2017Ikeda, Toru; Shinohata, Ryoko; Murakami, Masaaki; Hina, Kazuyoshi; Kamikawa, Shigeshi; Hirohata, Satoshi et al. (2017): A rapid and precise method for measuring plasma apoE-rich HDL using polyethylene glycol and cation-exchange chromatography: a pilot study on the clinical significance of apoE-rich HDL measurements. In Clinica Chimica Acta; International Journal of Clinical Chemistry 465, pp. 112–118. DOI: 10.1016/j.cca.2016.12.016.
[A03]2017Koch, Manja; Furtado, Jeremy D.; Jiang, Gordon Z.; Gray, Brianna E.; Cai, Tianxi; Sacks, Frank et al. (2017): Associations of anthropometry and lifestyle factors with HDL subspecies according to apolipoprotein C-III. In Journal of Lipid Research 58 (6), pp. 1196–1203. DOI: 10.1194/jlr.P073288.
[A03]2016Chen, Xueying; Bakillah, Ahmed; Zhou, Liye; Pan, Xiaoyue; Hoepfner, Florian; Jacob, Marrit et al. (2016): Nitrated apolipoprotein AI/apolipoprotein AI ratio is increased in diabetic patients with coronary artery disease. In Atherosclerosis 245, pp. 12–21. DOI: 10.1016/j.atherosclerosis.2015.11.021.
[A03]2016Ichimura, Naoya; Sato, Megumi; Yoshimoto, Akira; Yano, Kouji; Ohkawa, Ryunosuke; Kasama, Takeshi; Tozuka, Minoru (2016): High-Density Lipoprotein Binds to Mycobacterium avium and Affects the Infection of THP-1 Macrophages. In Journal of Lipids 2016, p. 4353620. DOI: 10.1155/2016/4353620.
[A03]2016Ma, Weilie; Lin, Margarita; Ding, Hang; Lin, Guorong; Zhang, Zhizhen (2016): β-COP as a Component of Transport Vesicles for HDL Apolipoprotein-Mediated Cholesterol Exocytosis. In PloS One 11 (3), e0151767. DOI: 10.1371/journal.pone.0151767.
[A03]2016Negi, Priyanka; Lövgren, Janita; Malmi, Päivi; Sirkka, Nina; Metso, Jari; Huovinen, Tuomas et al. (2016): Identification and analysis of anti-HDL scFv-antibodies obtained from phage display based synthetic antibody library. In Clinical Biochemistry 49 (6), pp. 472–479. DOI: 10.1016/j.clinbiochem.2015.11.020.
[A03]2016Singh, Sasha A.; Andraski, Allison B.; Pieper, Brett; Goh, Wilson; Mendivil, Carlos O.; Sacks, Frank M.; Aikawa, Masanori (2016): Multiple apolipoprotein kinetics measured in human HDL by high-resolution/accurate mass parallel reaction monitoring. In J. Lipid Res. 57 (4), pp. 714–728. DOI: 10.1194/jlr.D061432.
[A03]2016Yano, Kouji; Ohkawa, Ryunosuke; Sato, Megumi; Yoshimoto, Akira; Ichimura, Naoya; Kameda, Takahiro et al. (2016): Cholesterol Efflux Capacity of Apolipoprotein A-I Varies with the Extent of Differentiation and Foam Cell Formation of THP-1 Cells. In Journal of Lipids 2016, p. 9891316. DOI: 10.1155/2016/9891316.
[A03]2016Yassine, Hussein N.; Feng, Qingru; Chiang, Jiarong; Petrosspour, Larissa M.; Fonteh, Alfred N.; Chui, Helena C.; Harrington, Michael G. (2016): ABCA1-Mediated Cholesterol Efflux Capacity to Cerebrospinal Fluid Is Reduced in Patients With Mild Cognitive Impairment and Alzheimer"s Disease. In Journal of the American Heart Association 5 (2). DOI: 10.1161/JAHA.115.002886.
[A03]2015Kameda, Takahiro; Ohkawa, Ryunosuke; Yano, Kouji; Usami, Yoko; Miyazaki, Akari; Matsuda, Kazuyuki et al. (2015): Effects of Myeloperoxidase-Induced Oxidation on Antiatherogenic Functions of High-Density Lipoprotein. In Journal of Lipids 2015 (9), pp. 1–8. DOI: 10.1155/2015/592594.
[A03]2015Montecucco, Fabrizio; Braunersreuther, Vincent; Burger, Fabienne; Lenglet, Sébastien; Pelli, Graziano; Carbone, Federico et al. (2015): Anti-apoA-1 auto-antibodies increase mouse atherosclerotic plaque vulnerability, myocardial necrosis and mortality triggering TLR2 and TLR4. In Thromb Haemost 114 (08), pp. 410–422. DOI: 10.1160/TH14-12-1039.
[A03]2015Pagano, Sabrina; Gaertner, Hubert; Cerini, Fabrice; Mannic, Tiphaine; Satta, Nathalie; Teixeira, Priscila Camillo et al. (2015): The Human Autoantibody Response to Apolipoprotein A-I Is Focused on the C-Terminal Helix: A New Rationale for Diagnosis and Treatment of Cardiovascular Disease? In PLoS ONE 10 (7), e0132780. DOI: 10.1371/journal.pone.0132780.
[A03]2014Kalakech, Hussein; Hibert, Pierre; Prunier-Mirebeau, Delphine; Tamareille, Sophie; Letournel, Franck; Macchi, Laurent et al. (2014): RISK and SAFE Signaling Pathway Involvement in Apolipoprotein A-I-Induced Cardioprotection. In PLoS ONE 9 (9), e107950. DOI: 10.1371/journal.pone.0107950.
[A03]2014Miyazaki, Akari; Sagae, Nozomi; Usami, Yoko; Sato, Megumi; Kameda, Takahiro; Yoshimoto, Akira et al. (2014): N-homocysteinylation of apolipoprotein A-I impairs the protein’s antioxidant ability but not its cholesterol efflux capacity. In Biological Chemistry 395 (6). DOI: 10.1515/hsz-2013-0262.
[A03]2014Talayero, Beatriz; Wang, Liyun; Furtado, Jeremy; Carey, Vincent J.; Bray, George A.; Sacks, Frank M. (2014): Obesity favors apolipoprotein E- and C-III-containing high density lipoprotein subfractions associated with risk of heart disease. In J. Lipid Res. 55 (10), pp. 2167–2177. DOI: 10.1194/jlr.M042333.
[A03]2014Teixeira, Priscila Camillo; Ducret, Axel; Ferber, Philippe; Gaertner, Hubert; Hartley, Oliver; Pagano, Sabrina et al. (2014): Definition of Human Apolipoprotein A-I Epitopes Recognized by Autoantibodies Present in Patients with Cardiovascular Diseases. In J. Biol. Chem. 289 (41), pp. 28249–28259. DOI: 10.1074/jbc.M114.589002.
[A03]2012Chen, Zhu; Wang, Sheng-Ping; Krsmanovic, Mihajlo L.; Castro-Perez, Jose; Gagen, Karen; Mendoza, Vivienne et al. (2012): Small molecule activation of lecithin cholesterol acyltransferase modulates lipoprotein metabolism in mice and hamsters. In Metabolism 61 (4), pp. 470–481. DOI: 10.1016/j.metabol.2011.08.006.
[A03]2012Kameda, Takahiro; Usami, Yoko; Shimada, Saki; Haraguchi, Go; Matsuda, Kazuyuki; Sugano, Mitsutoshi et al. (2012): Determination of myeloperoxidase-induced apoAI-apoAII heterodimers in high-density lipoprotein. In Annals of Clinical and Laboratory Science 42 (4), pp. 384–391.
[A03]2012Nagao, Kohjiro; Kimura, Yasuhisa; Ueda, Kazumitsu (2012): Lysine residues of ABCA1 are required for the interaction with apoA-I. In Biochimica et Biophysica Acta 1821 (3), pp. 530–535. DOI: 10.1016/j.bbalip.2011.06.024.
[A03]2012Pagano, S.; Satta, N.; Werling, D.; Offord, V.; Moerloose, P. de; Charbonney, E. et al. (2012): Anti-apolipoprotein A-1 IgG in patients with myocardial infarction promotes inflammation through TLR2/CD14 complex. In Journal of Internal Medicine 272 (4), pp. 344–357. DOI: 10.1111/j.1365-2796.2012.02530.x.
[A03]2012Shen, Xun; Wang, Wei; Wang, Liangsu; Houde, Caroline; Wu, Weizhen; Tudor, Matt et al. (2012): Identification of genes affecting apolipoprotein B secretion following siRNA-mediated gene knockdown in primary human hepatocytes. In Atherosclerosis 222 (1), pp. 154–157. DOI: 10.1016/j.atherosclerosis.2012.02.012.
[A03]2012Usami, Yoko; Kobayashi, Yukihiro; Kameda, Takahiro; Miyazaki, Akari; Matsuda, Kazuyuki; Sugano, Mitsutoshi et al. (2012): Identification of sites in apolipoprotein A-I susceptible to chymase and carboxypeptidase A digestion. In Bioscience Reports 33 (1), pp. 49–56. DOI: 10.1042/BSR20120094.
[A03]2011Montecucco, Fabrizio; Vuilleumier, Nicolas; Pagano, Sabrina; Lenglet, Sébastien; Bertolotto, Maria; Braunersreuther, Vincent et al. (2011): Anti-Apolipoprotein A-1 auto-antibodies are active mediators of atherosclerotic plaque vulnerability. In European Heart Journal 32 (4), pp. 412–421. DOI: 10.1093/eurheartj/ehq521.
[A03]2011Rosales, Corina; Tang, Daming; Gillard, Baiba K.; Courtney, Harry S.; Pownall, Henry J. (2011): Apolipoprotein E Mediates Enhanced Plasma High-Density Lipoprotein Cholesterol Clearance by Low-Dose Streptococcal Serum Opacity Factor via Hepatic Low-Density Lipoprotein Receptors In Vivo. In Arterioscler Thromb Vasc Biol. 31 (8), pp. 1834–1841. DOI: 10.1161/ATVBAHA.111.224360.
[A03]2011Usami, Yoko; Matsuda, Kazuyuki; Sugano, Mitsutoshi; Ishimine, Nau; Kurihara, Yuriko; Sumida, Tamaki et al. (2011): Detection of chymase-digested C-terminally truncated apolipoprotein A-I in normal human serum. In Journal of Immunological Methods 369 (1-2), pp. 51–58. DOI: 10.1016/j.jim.2011.04.002.
[A03]2011Vickers, Kasey C.; Palmisano, Brian T.; Shoucri, Bassem M.; Shamburek, Robert D.; Remaley, Alan T. (2011): MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. In Nat Cell Biol 13 (4), pp. 423–433. DOI: 10.1038/ncb2210.
[A03]2011Wang, Yanan; Berbée, Jimmy F. P.; Stroes, Erik S.; Smit, Johannes W. A.; Havekes, Louis M.; Romijn, Johannes A.; Rensen, Patrick C. N. (2011): CETP expression reverses the reconstituted HDL-induced increase in VLDL. In J. Lipid Res. 52 (8), pp. 1533–1541. DOI: 10.1194/jlr.M016659.
[A03]2010Carballo-Jane, Ester; Chen, Zhu; O’Neill, Edward; Wang, Jun; Burton, Charlotte; Chang, Ching H. et al. (2010): ApoA-I mimetic peptides promote pre-β HDL formation in vivo causing remodeling of HDL and triglyceride accumulation at higher dose. In Bioorganic & Medicinal Chemistry 18 (24), pp. 8669–8678. DOI: 10.1016/j.bmc.2010.09.074.
[A03]2010Gruaz, Lyssia; Delucinge-Vivier, Céline; Descombes, Patrick; Dayer, Jean-Michel; Burger, Danielle (2010): Blockade of T Cell Contact-Activation of Human Monocytes by High-Density Lipoproteins Reveals a New Pattern of Cytokine and Inflammatory Genes. In PLoS ONE 5 (2), e9418. DOI: 10.1371/journal.pone.0009418.
[A03]2010Ishimine, N.; Usami, Y.; Nogi, S.; Sumida, T.; Kurihara, Y.; Matsuda, K. et al. (2010): Identification of N-homocysteinylated apolipoprotein AI in normal human serum. In Annals of Clinical Biochemistry 47 (Pt 5), pp. 453–459. DOI: 10.1258/acb.2010.010035.
[A03]2010Vuilleumier, N.; Rossier, M. F.; Pagano, S.; Python, M.; Charbonney, E.; Nkoulou, R. et al. (2010): Anti-apolipoprotein A-1 IgG as an independent cardiovascular prognostic marker affecting basal heart rate in myocardial infarction. In Thromb Haemost 31 (7), pp. 815–823. DOI: 10.1093/eurheartj/ehq055.
[A03]2010Vuilleumier, Nicolas; Bas, Sylvette; Pagano, Sabrina; Montecucco, Fabrizio; Guerne, Pierre-André; Finckh, Axel et al. (2010): Anti-apolipoprotein A-1 IgG predicts major cardiovascular events in patients with rheumatoid arthritis. In Arthritis and Rheumatism 62 (9), pp. 2640–2650. DOI: 10.1002/art.27546.
[A03]2009Kim, Soo In; Shin, Duckhyang; Lee, Hyeon; Ahn, Byung-Yoon; Yoon, Yeup; Kim, Meehyein (2009): Targeted delivery of siRNA against hepatitis C virus by apolipoprotein A-I-bound cationic liposomes. In Journal of Hepatology 50 (3), pp. 479–488. DOI: 10.1016/j.jhep.2008.10.029.
[A03]2009Vries-van der Weij, Jitske de; Haan, Willeke de; Hu, Lihui; Kuif, Maarten; Oei, H. Ling D. W.; van der Hoorn, José W. A. et al. (2009): Bexarotene Induces Dyslipidemia by Increased Very Low-Density Lipoprotein Production and Cholesteryl Ester Transfer Protein-Mediated Reduction of High-Density Lipoprotein. In Endocrinology 150 (5), pp. 2368–2375. DOI: 10.1210/en.2008-1540.
[A03]2008Chung, Kyung Min; Cha, Sun-Shin; Jang, Sung Key (2008): A novel function of karyopherin beta3 associated with apolipoprotein A-I secretion. In Molecules and Cells 26 (3), pp. 291–298.
[A03]2008Deng, Ting; Ji, Wei; Lian, Ji-Hong; Guo, Lei; Hu, Wei-Rong; Qian, Ming; Gong, Bang-qiang (2008): Identifying Natural Derived Upregulators of Human ApoA-I Expression via a Cell-Based Drug Screening System. In Pharmaceutical Biology 46 (9), pp. 610–615. DOI: 10.1080/13880200802179584.
[A03]2008He, Yubin; Greene, Diane J.; Kinter, Michael; Morton, Richard E. (2008): Control of cholesteryl ester transfer protein activity by sequestration of lipid transfer inhibitor protein in an inactive complex. In J. Lipid Res. 49 (7), pp. 1529–1537. DOI: 10.1194/jlr.M800087-JLR200.
[A03]2008Marchi, Nicola; Mazzone, Peter; Fazio, Vincent; Mekhail, Tarek; Masaryk, Thomas; Janigro, Damir (2008): ProApolipoprotein A1. In Cancer 112 (6), pp. 1313–1324. DOI: 10.1002/cncr.23314.
[A03]2007Kim, Soo In; Shin, Duckhyang; Choi, Tae Hyun; Lee, Jong Chan; Cheon, Gi-Jeong; Kim, Ki-Yong et al. (2007): Systemic and specific delivery of small interfering RNAs to the liver mediated by apolipoprotein A-I. In Molecular therapy : the Journal of the American Society of Gene Therapy 15 (6), pp. 1145–1152. DOI: 10.1038/sj.mt.6300168.
[A03]2007Matsuura, Fumihiko; Oku, Hiroyuki; Koseki, Masahiro; Sandoval, Jose C.; Yuasa-Kawase, Miyako; Tsubakio-Yamamoto, Kazumi et al. (2007): Adiponectin accelerates reverse cholesterol transport by increasing high density lipoprotein assembly in the liver. In Biochemical and Biophysical Research Communications 358 (4), pp. 1091–1095. DOI: 10.1016/j.bbrc.2007.05.040.
[A03]2006Guo, Lei; Hu, Wei-Rong; Lian, Ji-Hong; Ji, Wei; Deng, Ting; Qian, Ming; Gong, Bang-qiang (2006): Anti-hyperlipidemic properties of CM108 (a flavone derivative) in vitro and in vivo. In European Journal of Pharmacology 551 (1-3), pp. 80–86. DOI: 10.1016/j.ejphar.2006.08.048.
[A03]2006Thompson, Patricia A.; Kitchens, Richard L. (2006): Native high-density lipoprotein augments monocyte responses to lipopolysaccharide (LPS) by suppressing the inhibitory activity of LPS-binding protein. In J.I. 177 (7), pp. 4880–4887. DOI: 10.4049/jimmunol.177.7.4880.
[A03]2005Nedelkov, Dobrin; Kiernan, Urban A.; Niederkofler, Eric E.; Tubbs, Kemmons A.; Nelson, Randall W. (2005): Investigating diversity in human plasma proteins. In Proc Natl Acad Sci USA 102 (31), pp. 10852–10857. DOI: 10.1073/pnas.0500426102.
[A03]2005Tsujita, Maki; Wu, Cheng-Ai; Abe-Dohmae, Sumiko; Usui, Shinichi; Okazaki, Mitsuyo; Yokoyama, Shinji (2005): On the hepatic mechanism of HDL assembly by the ABCA1/apoA-I pathway. In J. Lipid Res. 46 (1), pp. 154–162. DOI: 10.1194/jlr.M400402-JLR200.
[A03]2004Gallagher, James W.; Weinberg, Richard B.; Shelness, Gregory S. (2004): apoA-IV tagged with the ER retention signal KDEL perturbs the intracellular trafficking and secretion of apoB. In J. Lipid Res. 45 (10), pp. 1826–1834. DOI: 10.1194/jlr.M400188-JLR200.
[A03]2004Pastore, Lucio; Belalcazar, L. Maria; Oka, Kazuhiro; Cela, Racel; Lee, Brendan; Chan, Lawrence; Beaudet, Arthur L. (2004): Helper-dependent adenoviral vector-mediated long-term expression of human apolipoprotein A-I reduces atherosclerosis in apo E-deficient mice. In Gene 327 (2), pp. 153–160. DOI: 10.1016/j.gene.2003.11.024.
[A03]2003Niederkofler, Eric E.; Tubbs, Kemmons A.; Kiernan, Urban A.; Nedelkov, Dobrin; Nelson, Randall W. (2003): Novel mass spectrometric immunoassays for the rapid structural characterization of plasma apolipoproteins. In J. Lipid Res. 44 (3), pp. 630–639. DOI: 10.1194/jlr.D200034-JLR200.
[A03]2003Yang, Chao-Yuh; Raya, Joe L.; Chen, Hsin-Hung; Chen, Chu-Huang; Abe, Yasunori; Pownall, Henry J. et al. (2003): Isolation, characterization, and functional assessment of oxidatively modified subfractions of circulating low-density lipoproteins. In Arterioscler Thromb Vasc Biol. 23 (6), pp. 1083–1090. DOI: 10.1161/01.ATV.0000071350.78872.C4.
[A03]2001Yuhanna, I. S.; Zhu, Y.; Cox, B. E.; Hahner, L. D.; Osborne-Lawrence, S.; Lu, P. et al. (2001): High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase. In Nature Medicine 7 (7), pp. 853–857. DOI: 10.1038/89986.
品牌介绍
自1995年以来,Academy生物医学公司一直致力于以合理的价格向心血管和动脉粥样硬化研究领域提供高质量的抗体。我们很荣幸为科学界提供我们致力于脂蛋白,载脂蛋白领域研究的抗体和试剂。 ,以及它们的氧化改性产物。